PRESS NMS NMS
What is the real situation of Nerviano Medical Sciences?
Before the planned meeting in late October in the Region of Lombardy, but returned by mid-November, the RSU has had more signs of NMS and confirmation, through an article and Espresso Press Release, Senator Massimo Garavaglia (Lega Nord, Vice President of the Senate Budget Commisiione) that the business situation is very heavy from the financial point of view (it has been approved and certified the 2009 Annual Report ?) and unclear regarding the corporate aspects (what is meant by other research centers in the south of Italy?). The RSU
NMS requests the Lombardy Region and the Company that the next meeting see a specific comparison not only on the economic / financial aspects but also corporate and future strategies of the Research Centre.
Recall that a comparison on these aspects was already provided a year ago with the agreement of all parties involved. We hope that this is the right time. The MSW
Nerviano Medical Sciences Nerviano, Tuesday, October 26, 2010
Press Release of Senator Massimo Garavaglia PDF
Article Espresso
Friday, October 29, 2010
Friday, October 8, 2010
Numbers As Status On Facebook?
The research goes on
A molecule developed in the laboratories of Nerviano Medical Sciences is report was included "The ones to watch" of Thomson Reuters.
Read the report in PDF format
Another promising molecule developed in Nerviano (NMS-116354) began Phase 1 clinical trials on humans in Galway in Ireland.
Read Original irishtimes.com
A molecule developed in the laboratories of Nerviano Medical Sciences is report was included "The ones to watch" of Thomson Reuters.
Read the report in PDF format
Another promising molecule developed in Nerviano (NMS-116354) began Phase 1 clinical trials on humans in Galway in Ireland.
Read Original irishtimes.com
Friday, October 1, 2010
Subscribe to:
Posts (Atom)